0001104659-22-024841.txt : 20220217
0001104659-22-024841.hdr.sgml : 20220217
20220217192656
ACCESSION NUMBER: 0001104659-22-024841
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220215
FILED AS OF DATE: 20220217
DATE AS OF CHANGE: 20220217
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kalkofen Donald A.
CENTRAL INDEX KEY: 0001771066
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37852
FILM NUMBER: 22650298
MAIL ADDRESS:
STREET 1: 7707 GATEWAY BOULEVARD, SUITE 140
CITY: NEWARK
STATE: CA
ZIP: 94560
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Protagonist Therapeutics, Inc
CENTRAL INDEX KEY: 0001377121
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 980505495
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7707 GATEWAY BLVD., SUITE 140
CITY: NEWARK
STATE: CA
ZIP: 94560-1160
BUSINESS PHONE: (510) 474-0170
MAIL ADDRESS:
STREET 1: 7707 GATEWAY BLVD., SUITE 140
CITY: NEWARK
STATE: CA
ZIP: 94560-1160
FORMER COMPANY:
FORMER CONFORMED NAME: Protagonist Therapeutics Inc
DATE OF NAME CHANGE: 20130605
FORMER COMPANY:
FORMER CONFORMED NAME: Protagonist Inc
DATE OF NAME CHANGE: 20061002
4
1
tm227111-4_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2022-02-15
0
0001377121
Protagonist Therapeutics, Inc
PTGX
0001771066
Kalkofen Donald A.
7707 GATEWAY BOULEVARD, SUITE 140
NEWARK
CA
94560
0
1
0
0
Chief Financial Officer
Common Stock
2022-02-15
4
A
0
7500
0.00
A
18521
D
Stock Option (right to buy)
28.73
2022-02-15
4
A
0
45000
0.00
A
2032-02-14
Common Stock
45000
45000
D
Represents grant of restricted stock units payable solely in common stock that will vest in three annual installments on February 15, 2023, 2024 and 2025.
Includes an aggregate of 635 shares acquired by the Reporting Person under the Issuer's 2016 Employee Stock Purchase Plan on March 9, 2021.
The stock option vests in 48 equal monthly installments following the date of grant.
/s/ Donald A. Kalkofen
2022-02-17